Evidence map›Paper›PMID 30249060›Full record

ArticleProteomes2018

Granulocyte-Colony-Stimulating Factor Alters the Proteomic Landscape of the Ventral Tegmental Area.

Nicholas L Mervosh, Rashaun Wilson, Navin Rauniyar, Rebecca S Hofford, Munir Gunes Kutlu, Erin S Calipari, TuKiet T Lam, Drew D Kiraly

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The role of gut-immune-brain signaling in substance use disorders.International review of neurobiology · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicholas L MervoshDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. nicholasmervosh@gmail.com.
Rashaun WilsonYale/NIDA Neuroproteomics Center, New Haven, CT 06511, USA. rashaun.wilson@yale.edu.
Navin RauniyarYale/NIDA Neuroproteomics Center, New Haven, CT 06511, USA. navin.rauniyar@yale.edu.
Rebecca S HoffordDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. rebecca.hofford@mssm.edu.
Munir Gunes KutluDepartment of Pharmacology, Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. gunes.kutlu@vanderbilt.edu.
Erin S CalipariDepartment of Pharmacology, Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. erin.calipari@vanderbilt.edu.
TuKiet T LamYale/NIDA Neuroproteomics Center, New Haven, CT 06511, USA. tukiet.lam@yale.edu.
Drew D KiralyDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. drew.kiraly@mssm.edu.
Icahn School of Medicine at Mount Sinai · USVanderbilt University · USAbterra Biosciences (United States) · US

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2004 to 2026
$37.1M
Dissecting the role of granulocyte-colony stimulating factor in cocaine-mediated behavioral plasticityK08DA044308 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIRALY, DREW · 2017 to 2021
$938k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingK99DA042111 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CALIPARI, ERIN · 2016 to 2017
$301k
Brain and Behavior Research Foundation Young InvestigatorNIDA NIH HHS DA018343NIDA NIH HHS DA042111NIDA NIH HHS DA044308NIDA NIH HHS K08 DA044308NIDA NIH HHS P30 DA018343
6 · The paper itself

Abstract

Cocaine addiction is characterized by aberrant plasticity of the mesolimbic dopamine circuit, leading to dysregulation of motivation to seek and take drug. Despite the significant toll that cocaine use disorder exacts on society, there are currently no available pharmacotherapies. We have recently identified granulocyte-colony stimulating factor (G-CSF) as a soluble cytokine that alters the behavioral response to cocaine and which increases dopamine release from the ventral tegmental area (VTA). Despite these known effects on behavior and neurophysiology, the molecular mechanisms by which G-CSF affects brain function are unclear. In this study mice were treated with repeated injections of G-CSF, cocaine or a combination and changes in protein expression in the VTA were examined using an unbiased proteomics approach. Repeated G-CSF treatment resulted in alterations in multiple signaling pathways related to synaptic plasticity and neuronal morphology. While the treatment groups had marked overlap in their effect, injections of cocaine and the combination of cocaine and G-CSF lead to distinct patterns of significantly regulated proteins. These experiments provide valuable information as to the molecular pathways that G-CSF activates in an important limbic brain region and will help to guide further characterization of G-CSF function and evaluation as a possible translational target.

Indexed as

addictioncocainecytokineneuroimmuneventral tegmental area

Identifiers

PMID30249060
PMCPMC6313867
OpenAlexW2890240462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.